BNGO - Bionano Genomics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
11,354
12,001
9,505
6,793
Cost of Revenue
8,066
8,711
6,031
3,579
Gross Profit
3,288
3,289
3,475
3,214
Operating Expenses
Research Development
9,203
9,484
12,009
11,432
Selling General and Administrative
18,898
14,220
14,080
12,951
Total Operating Expenses
28,101
23,704
26,089
24,383
Operating Income or Loss
-24,813
-20,415
-22,614
-21,168
Interest Expense
1,683
1,381
591
470
Total Other Income/Expenses Net
-1,807
3,315
-142
2,803
Income Before Tax
-28,303
-18,481
-23,347
-18,836
Income Tax Expense
23
16
19
13
Income from Continuing Operations
-28,326
-18,496
-23,365
-18,849
Net Income
-28,326
-18,496
-23,365
-18,849
Net Income available to common shareholders
-28,326
-18,496
-23,365
-18,849
Reported EPS
Basic
-
-1.84
-8.65
-3.61
Diluted
-
-1.84
-8.65
-3.61
Weighted average shares outstanding
Basic
-
10,055
2,701
5,227
Diluted
-
10,055
2,701
5,227
EBITDA
-
-15,779
-21,252
-17,251